重症监护病房家庭支持干预的随机试验
该阶梯楔形整群随机试验在5个ICU纳入1420例高死亡风险患者及其代理人,比较跨专业ICU团队提供的多组分家庭支持干预与常规照护。主要终点6个月代理人HADS平均评分两组无显著差异(11.7 vs 12.0;β=-0.34;95%CI -1.67至0.99;P=0.61),IES评分亦无显著差异(21.2 vs 20.3;β=0.90;95%CI -1.66至3.47;P=0.49)。干预组QOC评分更优(69.1 vs 62.7;β=6.39;95%CI 2.57至10.20;P=0.001),改良PPPC评分更优(1.7 vs 1.8;β=-0.15;95%CI -0.26至-0.04;P=0.006)。干预组ICU平均住院时间更短(6.7天 vs 7.4天;发生率比0.90;95%CI 0.81至1.00;P=0.045),该效应由死亡患者ICU住院时间缩短所介导(4.4天 vs 6.8天;发生率比0.64;95%CI 0.52至0.78;P<0.001)。
要点
- 在5个ICU的1420例高死亡风险患者中,跨专业团队家庭支持干预未显著降低代理人6个月HADS评分(11.7 vs 12.0;β=-0.34;95%CI -1.67至0.99;P=0.61)。
- 干预未显著改善代理人6个月IES评分(21.2 vs 20.3;β=0.90;95%CI -1.66至3.47;P=0.49)。
- 干预组代理人QOC沟通质量评分优于常规照护(69.1 vs 62.7;β=6.39;95%CI 2.57至10.20;P=0.001)。
- 干预组改良PPPC以患者家庭为中心评分优于常规照护(1.7 vs 1.8;β=-0.15;95%CI -0.26至-0.04;P=0.006)。
- 干预组ICU平均住院时间短于常规照护(6.7天 vs 7.4天;发生率比0.90;95%CI 0.81至1.00;P=0.045),由死亡患者住院时间缩短介导(4.4天 vs 6.8天;发生率比0.64;95%CI 0.52至0.78;P<0.001)。
适用人群与场景
- 5个ICU中高死亡风险的患者及其代理人。
处置流程与药物剂量
- 由跨专业ICU团队提供多组分家庭支持干预,与常规照护对照。
研究设计与关键结果
- 阶梯楔形整群随机试验,纳入1420例患者,比较跨专业ICU团队多组分家庭支持干预与常规照护。
- 主要终点6个月代理人HADS平均评分两组无显著差异(干预组11.7 vs 对照组12.0;β=-0.34;95%CI -1.67至0.99;P=0.61)。
- 代理人IES平均评分两组无显著差异(干预组21.2 vs 对照组20.3;β=0.90;95%CI -1.66至3.47;P=0.49)。
- 代理人QOC平均评分干预组优于对照组(69.1 vs 62.7;β=6.39;95%CI 2.57至10.20;P=0.001)。
- 改良PPPC平均评分干预组优于对照组(1.7 vs 1.8;β=-0.15;95%CI -0.26至-0.04;P=0.006)。
- ICU平均住院时间干预组短于对照组(6.7天 vs 7.4天;发生率比0.90;95%CI 0.81至1.00;P=0.045),由死亡患者ICU平均住院时间缩短介导(4.4天 vs 6.8天;发生率比0.64;95%CI 0.52至0.78;P<0.001)。
证据类型、等级与局限
- 研究类型:阶梯楔形整群随机试验(PARTNER,ClinicalTrials.gov NCT01844492)。
- 资助:UPMC Health System和Greenwall Foundation。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在高死亡风险重症患者及其代理人中,跨专业ICU团队实施的多组分家庭支持干预未显著影响代理人心理症状负担,但代理人沟通质量评分和以患者家庭为中心的照护评分更好,且ICU住院时间更短。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Surrogate decision makers for incapacitated, critically ill patients often struggle with decisions related to goals of care. Such decisions cause psychological distress in surrogates and may lead to treatment that does not align with patients' preferences.
METHODS: We conducted a stepped-wedge, cluster-randomized trial involving patients with a high risk of death and their surrogates in five intensive care units (ICUs) to compare a multicomponent family-support intervention delivered by the interprofessional ICU team with usual care. The primary outcome was the surrogates' mean score on the Hospital Anxiety and Depression Scale (HADS) at 6 months (scores range from 0 to 42, with higher scores indicating worse symptoms). Prespecified secondary outcomes were the surrogates' mean scores on the Impact of Event Scale (IES; scores range from 0 to 88, with higher scores indicating worse symptoms), the Quality of Communication (QOC) scale (scores range from 0 to 100, with higher scores indicating better clinician-family communication), and a modified Patient Perception of Patient Centeredness (PPPC) scale (scores range from 1 to 4, with lower scores indicating more patient- and family-centered care), as well as the mean length of ICU stay.
RESULTS: A total of 1420 patients were enrolled in the trial. There was no significant difference between the intervention group and the control group in the surrogates' mean HADS score at 6 months (11.7 and 12.0, respectively; beta coefficient, -0.34; 95% confidence interval [CI], -1.67 to 0.99; P=0.61) or mean IES score (21.2 and 20.3; beta coefficient, 0.90; 95% CI, -1.66 to 3.47; P=0.49). The surrogates' mean QOC score was better in the intervention group than in the control group (69.1 vs. 62.7; beta coefficient, 6.39; 95% CI, 2.57 to 10.20; P=0.001), as was the mean modified PPPC score (1.7 vs. 1.8; beta coefficient, -0.15; 95% CI, -0.26 to -0.04; P=0.006). The mean length of stay in the ICU was shorter in the intervention group than in the control group (6.7 days vs. 7.4 days; incidence rate ratio, 0.90; 95% CI, 0.81 to 1.00; P=0.045), a finding mediated by the shortened mean length of stay in the ICU among patients who died (4.4 days vs. 6.8 days; incidence rate ratio, 0.64; 95% CI, 0.52 to 0.78; P<0.001).
CONCLUSIONS: Among critically ill patients and their surrogates, a family-support intervention delivered by the interprofessional ICU team did not significantly affect the surrogates' burden of psychological symptoms, but the surrogates' ratings of the quality of communication and the patient- and family-centeredness of care were better and the length of stay in the ICU was shorter with the intervention than with usual care. (Funded by the UPMC Health System and the Greenwall Foundation; PARTNER ClinicalTrials.gov number, NCT01844492 .).
参考来源
- White DB, Angus DC, Shields AM, et al. A Randomized Trial of a Family-Support Intervention in Intensive Care Units. N Engl J Med. 2018. PMID: 29791247. doi:10.1056/NEJMoa1802637
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。